Lifescience Dynamics Limited
Adam Pow has a diverse work experience spanning across different industries. Adam started their career in 2009 as a Summer Intern at Deloitte in the Enterprise Risk Services department. After that, they worked as a Research Assistant and Technician at BC Children's Hospital from 2016 to 2017, where they worked under Dr. Mark Chilvers, Dr. Connie Yang, and Dr. [no author specified]. Adam then transitioned to Lifescience Dynamics Limited, where they have held various roles. Adam started as a Junior Business Analyst from September 2020 to August 2021, then became a Business Analyst from August 2021 to September 2022. Currently, they hold the position of Senior Business Analyst at Lifescience Dynamics Limited, starting in September 2022.
Adam Pow obtained an Associate of Science (A.S.) degree in Biology/Biological Sciences, General from Capilano University in 2014. From 2014 to 2018, they attended The University of British Columbia and earned a Bachelor of Science (B.Sc.) degree in Biology/Biological Sciences, General. Adam then pursued a Master's degree in European Health Economics and Management (EU-HEM) from both Erasmus University Rotterdam and MCI | The Entrepreneurial School® from 2018 to 2020. Additionally, they obtained certifications like TCPS 2: CORE from the Government of Canada in May 2015, and UBC Biological Safety Training and UBC Chemical Safety Training from The University of British Columbia in November 2016 and December 2016, respectively.
Lifescience Dynamics Limited
Lifescience Dynamics few blockbuster drugs on the horizon and many key disease areas well served by generics, innovation in the pharmaceutical market now focuses on precision and targeted medicine including biologics, regenerative and gene therapies. In these challenging times, pharmaceutical and biotech clients require a thought partner fordecision support, and it is here that Lifescience Dynamics is second-to-none.